Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands
William C Florence, Chengfeng Xia, Laura E Gordy, Wenlan Chen, Yalong Zhang, James Scott-Browne, Yuki Kinjo, Karl OA Yu, Santosh Keshipeddy, Daniel G Pellicci, Onisha Patel, Lars Kjer-Nielsen, James McCluskey, Dale I Godfrey, Jamie Rossjohn, Stewart K Richardson, Steven A Porcelli, Amy R Howell, Kyoko Hayakawa, Laurent Gapin Show all
EMBO Journal | WILEY | Published : 2009
Awarded by NIH
We thank L Van Kaer for critical evaluation of the data and helpful suggestions on the writing of this paper. This work was supported by grants from the NIH HL069765 (WCF, LEG) AI007611 (LEG), AI45889 (SAP), AI057519 (ARH), AI074952 (DMZ), AI048224 and AI061721 (SJ), as well as by the Medical Scientist Training Program of the Albert Einstein College of Medicine (KAOY), the Cancer Research Institute's Investigator Award (DMZ) and an endowment from the Ohio State University (PGW).